Abstract
Introduction: type 2 diabetes mellitus (T2DM) is a chronic metabolic disease requiring comprehensive management of multiple risk factors including blood glucose (BG), blood pressure, and lipids. It to investigate the clinical effects of individualized nutrition and insulin pump therapy guided by continuous glucose monitoring (CGM) based on the quality circle control (QCC) nursing model in T2DM patients and its effect on Fasting C-peptide (FC-P), fasting plasma glucose (FPG), 2-hour postprandial glucose (2 hPG), fasting insulin (FIns), and glycated hemoglobin (HbA1c).
Materials and Methods: eighty T2DM patients treated at our hospital from January 2023 to January 2024 were recruited and rolled into a research group (EG) receiving individualized nutrition and insulin pump therapy guided by CGM based on the QCC nursing model, and a regular group (RG) receiving routine care and treatment. Differences of BG control, insulin usage, CGM downtime, and anomaly occurrence rate were compared between groups.
Results: EG showed marked improvements relative to RG in mean fasting C-peptide (FC-P), fasting plasma glucose (FPG), postprandial 2-hour glucose (2 hPG), fasting insulin (FIns), and glycated hemoglobin (HbA1c) levels (P<0.05). It also reduced time to achieve BG targets, lowered glucose variability and insulin dosage, and decreased the incidence of CGM system anomalies (P<0.05). Treatment effectiveness and nursing satisfaction were markedly higher in EG versus RG (P<0.05).
Conclusion: the QCC nursing model effectively enhances BG control, optimizes insulin therapy, improves dietary habits and quality of life, and reduces hypoglycemic events in T2DM patients. This model deserves promotion and application in clinical practice.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.